AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer
The approval for AstraZeneca molecule is based on the findings of TOPAZ-1, a Phase-3 global clinical trial with patients recruited…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.